Jean–Yves Mary - Concepedia

Author

Jean–Yves Mary

Also Known As

J Y MARY, J Y Mary, J. Y. MARY, J. Y. Mary, J.-Y Mary, J.-Y. Mary, J.Y. Mary, JEAN-YVES MARY, Janevic Mary, Jean-Yves Mary

174

Publications

10.6K

Citations

H-Index

111

Concepts

All Affiliations

Inserm Université Paris Cité Hôpital Saint-Louis Sorbonne Université Délégation Paris 7

About

Jean–Yves Mary is an author at Inserm specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	36	4.6K
2	Public Health	6	6	284
3	Health Sciences	3	3	346
4	Engineering	2	2	58
5	Biochemistry	2	2	59

Jean–Yves Mary

Publications

9.9K

Citations

H-Index

Page 1

	Year	Citations
Clinical, biological, and endoscopic picture of attacks of Crohn's disease R Modigliani, Jean–Yves Mary, Jean-François Simon, Gastroenterology Endoscopic PictureGastroenterologyPathologyGi TechniqueSurgery	1990	705
Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Simon Travis, Dan Schnell, Piotr Krzeski, Gut	2011	607
Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped Édouard Louis, Jean–Yves Mary, Gwénola Vernier-Massouille, Gastroenterology InflammationAntimetabolite TherapyAnti-inflammatoryGastroenterologySurgery	2011	589
Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors Gèrard Socié, Jean–Yves Mary, Aimery de Gramont, The Lancet HemodialysisUrologySleepMedicineHematology	1996	513
Reliability and Initial Validation of the Ulcerative Colitis Endoscopic Index of Severity Simon Travis, Dan Schnell, Piotr Krzeski, Gastroenterology	2013	435
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. C. Chapuis Cellier, Tarek Sahmoud, Eric Froguel, Gut	1994	434
Infliximab Plus Azathioprine for Steroid-Dependent Crohn’s Disease Patients: A Randomized Placebo-Controlled Trial Marc Lémann, Jean–Yves Mary, Bernard Duclos, Gastroenterology InflammationAnti-inflammatoryInfliximab Plus AzathioprineRandomized Placebo-controlled TrialImmunology	2006	370
A Randomized, Double-Blind, Controlled Withdrawal Trial in Crohn’s Disease Patients in Long-term Remission on Azathioprine Marc Lémann, Jean–Yves Mary, Jean‐Frédéric Colombel, Gastroenterology Long-term RemissionGastroenterologyClinical GastroenterologyPharmacotherapyUlcerative Colitis	2005	347
Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study Yoram Bouhnik, Franck Carbonnel, David Laharie, Gut	2017	315
Chromosome 13 abnormalities identified by FISH analysis and serum β2-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy Thierry Façon, Hervé Avet‐Loiseau, Gaëlle Guillerm, Blood	2001	313

Page 1